Abiopharma

Cidara Therapeutics to Participate in November Investor Conferences

Cybin Announces $175 Million Registered Direct Offering

Soleno Therapeutics to Participate in Upcoming November Conferences

Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4

BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025